Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 3057-3064

  Norrby Teglund, Anna ^a   Kaul, Rupert ^b   Low, Donald E ^b   McGeer, Allison ^b   Newton, Duane W ^a,d   Andersson, Jan ^c   Andersson, Ulf ^c   Kotb, Malak ^a,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; SUPERANTIGEN;

ARTICLE; BIOSYNTHESIS; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; PLASMA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE;

CYTOKINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; PLASMA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0030584899     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cone, L. A , D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987, Clinical and bacteriological observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl. J Med. 3:140
2. Gaworzewska, E., and G Colman. 1988. Changes in the pattern of infections caused by Streptococcus, pyogenes Epidemiol Infect. 100.257
3. Martin, P. R., and E A Hoiby 1990. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand. J. Infect Dis. 22-421
4. Stromberg, A. V. Romanus, and L G Burman. 1991, Outbreak of group A streptococcal bacteremia in Sweden an epidemiological and clinical study. J. Infect Dis 164:595.
5. Stevens, D. L. 1992. Invasive group A streptococcus infections Clin. Infect. Dis. 14.2.
6. Parker, M. M , and J. E. Parillo. 1983. Septic shock. Hemodynamics and pathogenesis JAMA 250:3324.
7. Bone, R. C 1991. The pathogenesis of sepsis. Ann Intern Med. 115-457.
8. Demers, B., A.-E. Simor, H. Vellend, P. M. Schlievert, S. Byrne, F. Jamieson. S. Valmsley, and D. E Low. 1993. Severe invasive group A streptococcal infections in Ontario, Canada 1987-1991. Clin. Infect. Dis. 16:792.
9. Stevens, D. L., A. Bryant, and S. P. Hackett. 1993 Sepsis syndromes and toxic shock syndromes: concept in pathogenesis and perspective of future treatment strategies. Curr. Opin. Infect. Dis. 6:374.
10. Barry, W., L. Hudgins, S. T. Donta, and E L. Pesanti 1992, Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267:3315
11. Nadal, D., R. P. Lauener, C. P Braegger, A. Kaufhold, B. Simma, R. Lutticken, and R. A Seger. 1993. T cell activation and cytokine release in streptococcal toxic shock-like syndrome J. Pediatr. 122:727.
12. Chelsom, J , A. Halstensen, T. Haga, and A. Hoiby. 1994. Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features Lancet 344:1111.
13. Smith, R. J . P M. Schlievert, I. M. Himelright, and L. M. Baddour. 1994. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C. Diagn. Microbiol. Infect. Dis. 19:245
14. McGeer, A., K. Green, D. Cann, B. Schwartz, R. Kaul, A. Fletcher, S. Matsumura, Ontario group A streptococcal study group, and D. E. Low. 1995. Changing epidemiology of invasive group A streptococcal infections-population based surveillance, Ontario, Canada. 1992-5 In 35th Interscience Conference of Antimicrobial Agents and Chemotherapy, p. K135 (Abstr.). American Society for Microbiology, Washington, D.C.
15. Stevens, D. L , M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321-1.
16. Bohach, G. A , D. J. Fast, R D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev. Microbiol. 17:251.
17. Hauser, A. R , D. L. Stevens, E. L. Kaplan, and P. M. Schlievert 1991 Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome J. Clin. Microbiol. 29:1562.
18. Musser, J M., A. R. Hauser, M. H. Kim, P. M Schlievert, K. Nelson, and R. K. Selander 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl. Acad. Sci. USA 88:2668.
19. Cleary, P. P., E. L. Kaplan, J. P. Handley, A. Wlazlo, M. H. Kim, A. R. Hauser, and P. M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s Lancet 339:518
20. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992 Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166:31.
21. Norrby-Teglund, A., K. Pauksens, S. E. Holm, and M. Norgren. 1994. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect Dis. 170:585.
22. Watanabe-Ohnishi, R., D E. Low, A. McGeer, D. L. Stevens, P. M. Schlievert, D. Newton, B Schwartz, B. Kreiswirth, Ontario streptococcal study project, and M. Kotb. 1995. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J Infect. Dis. 171:74
23. Wannamaker, L W., and P. M. Schlievert. 1988. Exotoxins of group A streptococci. In Bacterial Toxins. M. C. Hardegree and A T Tu, eds. Marcel Dekker, New York, p. 267.
24. Abe, J., J. Forrester, N. Takako, J. A Lafferty, B. L. Kotzin, and D Y. M. Leung. 1991. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J. Immunol. 146:3747
25. Alouf, J. E , H. Knoll, and W. Kohler. 1991. The family of mitogenic, shock-inducing and superantigenic toxins from staphylococci and streptococci. In Sourcebook of Bacterial Protein Toxins J. E. Alouf and J. H. Freer, eds. Academic Press, San Diego, p. 367.
26. Tomai, M., P. M Schlievert, and M. Kotb. 1992 Distinct T cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and M protein. Infect. Immun. 60:701.
27. Kotb. M 1995. Bacterial pyrogenic exotoxins as superantigens Clin. Microbiol. Rev. 8:411.
28. Fraser, J. D. 1989. High affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339.221.
29. Janeway, C. A., J. Yagi, P. J. Conrad, M. F. Katz, B. Jones, S. Vroegop, and S. Buxser. 1989. T cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol. Rev 107.61
30. Mollick, J. A., R. G. Cook, and R. R. Rich 1989. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science 244:817.
31. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705.
32. Fleisher, B., R. Gerardy-Schan, B. Metzroth, S. Carrel, D Gerlach, and W. Kohler. 1991. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol. 146:11.
33. Hackett, S. P., and D. L. Stevens. 1992. Streptococcal toxic shock syndrome synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J. Infect. Dis. 165:879
34. Johnson, H. M., J. K. Russell, and C Pontzer. 1992. Superantigens in human disease. Sci. Am 266:92.
35. Kotb, M. 1992. Role of superantigens in the pathogenesis of infectious diseases and their sequelae Curr. Opin. Infect. Dis. 5:364.
36. Kotzin, B. L., D. Y. Leung, J. Kappler, and P Marrack 1993 Superantigens and their potential role in human disease. Adv. Immunol. 54:99
37. Schlieveit, P M 1993. Role of superantigens in human diseases. J. Infect. Dis. 167:997
38. Norrby-Teglund, A., M. Norgren, S. E. Holm, U Andersson, and J. Andersson 1994. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect. Immun, 62:3731.
39. Choi, Y., J. A Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B L. Kotzin. 1990. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172:981.
40. Michie, C., A. Scott, J. Cheesbrough, P. Beverly, and G. Pasvol. 1994. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effect on T lymphocyte subsets in vivo. Clin. Exp. Immunol 98:140.
41. Köhler, W. 1992. Epidemiology and pathogenesis of streptococcal infection. Immun. Infekt. 20:92.
42. Takei, S , Y. K. Arora, and S. M. Walker. 1993. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 91:602
43. Newburger, J. W., M. Takahashi, J. C. Burns, A. S. Beiser, K. J. Chung, C E. Duffy, M P Glode, W. H Mason, V. Reddy, S. P. Sanders, S. T. Shulman, J. W Wiggins, R. V. Hicks, D. R Fulton, A B Lewis, D. Y. M. Leung, T. Colton, F. S. Rosen, and M. E. Melish. 1986. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl. J. Med. 315:341.
44. Klassen, T. P., P. C. Rowe, and A Gafni. 1993. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome. J Pediatr. 122:538.
45. Burns, J. C., and T. Matsubara. 1995. Kawasaki disease. Trends Cardiovasc. Med. 5:3
46. Ogawa, M., S. Ueda, N. Anzai, K Ito, and M. Ohto. 1995. Toxic shock syndrome after staphylococcal pneumonia treated with intravenous immunoglobulin. Vox Sang. 68:59.
47. The Working Group on Severe Streptococcal Infections 1993 Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 269.390.
48. Kaul, R., A. McGeer, Canadian Infectious Disease Society (CIDS) Ontario streptococcal study group, A. Norrby-Teglund, M Kotb, and D. E. Low. 1995 Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study. In 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. LM68 (Abstr). American Society for Microbiology, Washington, D.C.
49. Sander, B., J. Andersson, and U. Andersson. 1991 Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure Immunol. Rev 119:65.
50. Andersson, J., S. Nagy, L Björk, J. Abrams, S. Holm, and U. Andersson. 1992. Bacterial toxin-induced cytokine production studied at the single-cell level Immunol. Rev. 127:69.
51. Mollick, J A., G G. Miller, R. G. Cook, D. Grossman, and R. R. Rich. 1993 A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin. Invest. 92:710.
52. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 163. 1177.
53. Sullivan, G. W., and G. L Mandell. 1991. The role of cytokines in infection. Curr. Opin. Infect Dis. 4:344.
54. Cerami, A. 1992. Inflammatory cytokines Clin Immunol Immunopathol. 62:3.
55. Svenson, M., M. B. Hansen, and K Bendtzen. 1993. Binding of cytokines to pharmaceutically prepared human immunoglohulin. J. Clin. Invest. 92:2533.
56. Skansen-Saphir, U , J. Andersson, L. Björk, and U. Andersson. 1994. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur. J. Immunol. 24.916.
57. Stegmayer, B., S Björck, S. Holm, J. Nisell, A Rydvall, and B. Settergren 1992 Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand. J. Infect Dis. 24:589.
58. Gjorloff, A., H. Fisher, G. Hedlund, J. Hansson, S. Kenny, A.-C. Allison, H.-O. Sjögren, and M. Dohlsten. 1991. Induction of IL-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells Cell. Immunol. 137:61
59. Grossman, D., J. G Lamphear, J. A. Mollick, M. J. Betley, and R. R. Rich. 1992. Dual role for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect. Immun 60:5190.
60. Kotb, M., H. Ohnishi, G. Majumdar, S Hackett, A Bryant, G. Higgins, and D. Stevens. 1993. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect Immun. 61:1194.
61. Rand, K. H , K. Gibbs, H Derendorf, and J. Graham-Pole. 1991. Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients. J. Clin. Pharmacol. 31:1151